Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-20

Clinical Trial Update: The Protection Effect of Speeda® Rabies Vaccine for Human Use [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the protective effect of Speeda Rabies Vaccine in humans; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Speeda Rabies Vaccine (rabies vaccine)

Snippet

Sponsor: Beijing Center for Disease Control and Prevention | Conditions: Rabies Vaccine Allergy | Phase 4 | Status: COMPLETED